Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
about
Phenylethanoid Glycosides: Research Advances in Their Phytochemistry, Pharmacological Activity and PharmacokineticsThe Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular DementiaOxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats.Selective Vulnerabilities of N-methyl-D-aspartate (NMDA) Receptors During Brain Aging.Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.Brain ageing in the new millennium.Piracetam improves mitochondrial dysfunction following oxidative stress.Tart cherry juice decreases oxidative stress in healthy older men and women.A neurovascular perspective for long-term changes after brain trauma.Neuroprotective compounds of Tilia amurensis.Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.Role of long-term potentiation of sympathetic ganglia (gLTP) in hypertension.Oxidative stress in older adults: effects of physical fitness.Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptomsThe energy-redox axis in aging and age-related neurodegeneration.The beneficial role of vitamin D in Alzheimer's disease.From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.L-arginine and nitric oxide in CNS function and neurodegenerative diseases."Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Protective effects of decursin and decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes.mt-Nd2a suppresses reactive oxygen species production by mitochondrial complexes I and III.Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicityProtein expression is altered during spontaneous sleep in aged Sprague Dawley rats.Brain cell apoptosis inhibition by butylphthalide in Alzheimer's disease model in rats.Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease.Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach.Anti-inflammatory effects of Z-ligustilide nanoemulsion.Souvenaid®: a new approach to management of early Alzheimer's disease.Influence of apolipoprotein E polymorphism on plasma vitamin A and vitamin E levels.Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress.Emerging Roles of Ganoderma Lucidum in Anti-Aging.Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells.Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury.Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats.Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α.The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration.
P2860
Q26740011-BA08AB00-5353-43B2-9CD2-88290D07AE6CQ26795415-28F62ACA-0320-4DA1-8D62-9CE0FD2DC215Q31962000-AC0CF0D9-664F-44D4-8345-916645D0BAFCQ33868364-6AB1CC0F-488B-4EC8-8467-2B2552B4EDECQ34426624-93B3CBD8-66C1-47AA-AEE5-CC93CB4CDDBAQ34625093-26D686B5-CC8D-4A95-8B2E-B7D23757D9D7Q35098643-0917E2EF-F7BF-4682-90EE-C744E444F699Q35149939-4C7CD146-77BE-4EE0-93FA-722AA44776FFQ35763336-15BB1A48-2407-4017-9801-3198E3B38347Q36300759-74552D28-F4CD-4A27-8D9C-96DB68284E5EQ36346512-6531D187-A48F-42B0-BC76-100AB4D7E548Q36892332-F84FD66E-EEBF-4467-A254-F0EC145A5367Q36927518-61AAA58E-94D4-4146-B2B0-6FC1C3954159Q37111515-B8C89E55-F7C2-49B7-B263-EFFA58A37228Q37165080-38F26D56-6F4A-4140-A071-AE0C7BF5A400Q37588978-EB95CB6F-6431-4327-9361-FA92C2AB151EQ37971804-F257903C-CF4A-4559-8CA7-A0493101BA9FQ38029575-3052E6BB-27F9-478E-9858-FCB41BDF0FC5Q38108100-4820140D-9EE8-48BE-9BAB-E59A01EC9798Q38134415-55FFF839-D2DE-4F99-9DF8-D2D3E47314C4Q38441500-7AE8FEFA-8E15-4379-8EFC-DAB49F3887FFQ39578575-86F5812A-F8B1-4DBF-A1F2-F81F76982DC4Q39783160-6017AB03-FFF9-4B5D-B97D-170900732EEEQ39904120-38137AEE-ED67-4754-8116-423EC8CA922BQ41944249-DF3472E5-846F-456C-912A-CA9F5FFC144CQ41976389-D7504B76-0FD5-4DA6-B2A0-A9E593124710Q42245451-9633C9B4-EDF6-4587-98A8-1A5D07DC924EQ42368761-C3CE98EE-BFCE-4990-8E42-A2171704E1EEQ43803360-684BF514-3CC8-4504-A234-E5C854244CBAQ43864462-396590F0-5B87-4DDC-B7ED-8A5CD350CE46Q43959120-9B30F07B-39F1-4C14-8C62-0B52B92399A8Q44495019-F2A107C4-1209-484E-8095-9CF6199C2E26Q47712151-C7D8C9B5-7FFD-45A3-B460-9E2FF309C779Q48587234-8826B07A-666B-45D4-BA45-68F332BEB07FQ48595101-83C36850-2560-4834-8309-902A6A19499FQ49718221-D762E01A-077C-4D71-A895-C2536BDFB348Q50556631-F2D1845E-2992-45A6-AE52-EE5C1C9B4B34Q51776741-14EBFCFE-EEE1-4FF4-AC1C-E3E50CE34579Q53357505-289CCA7E-DE8C-45FD-9D89-D657A558C870Q55658995-DEE411D4-900A-461B-9FC6-79AA0DCE9CE1
P2860
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@ast
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@en
type
label
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@ast
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@en
prefLabel
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@ast
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@en
P2093
P1433
P1476
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
@en
P2093
Aksenova M
Butterfield DA
Harris-White ME
Pedigo NW Jr
P304
P356
10.1016/S0024-3205(99)00442-7
P407
P577
1999-01-01T00:00:00Z